REPAIRing What We Can't See: The Need for Imaging Endpoints in PAH Clinical Trials
- PMID: 34801460
- DOI: 10.1016/j.jcmg.2021.09.006
REPAIRing What We Can't See: The Need for Imaging Endpoints in PAH Clinical Trials
Keywords: cardiovascular magnetic resonance; pulmonary arterial hypertension; right ventricle.
Conflict of interest statement
Funding Support and Author Disclosures The author has reported that he has no relationships relevant to the contents of this paper to disclose.
Comment on
-
The REPAIR Study: Effects of Macitentan on RV Structure and Function in Pulmonary Arterial Hypertension.JACC Cardiovasc Imaging. 2022 Feb;15(2):240-253. doi: 10.1016/j.jcmg.2021.07.027. Epub 2021 Nov 17. JACC Cardiovasc Imaging. 2022. PMID: 34801462